Advertisement

Opioid News

April 17, 2017
April 17, 2017
It seems not a day goes by without a headline about the opioid crisis, yet for all the media blitz, many parents may be missing a crucial point...
Information about safety shouldn’t get lost in the buzz about opioids
MORE
April 11, 2017
April 11, 2017
While still encouraging their implementation, CMS’s final call letter does not require sponsors to incorporate hard opioid safety edits at the 200-...
CMS’s final call letter addresses several issues raised by APhA
MORE
April 03, 2017
April 03, 2017
JAPhA has published a special issue entitled “Opioids, Naloxone, and Beyond: The Intersection of Medication Safety, Public Health, and Pharmacy.”...
30 articles on a timely topic for pharmacists
MORE
April 03, 2017
April 03, 2017
Patients who take opioids for more than 5 days are more likely to continue taking them long-term, according to a study appearing in CDC’s March 17...
MMWR report describes characteristics of long-term opioid users
MORE
March 25, 2017
March 25, 2017
Keynote speaker Elliot J. Krane, MD, punctured myths about opioids and addiction in an electric, riveting presentation to attendees at the Opening...
Pain physician Krane delivers keynote at Opening General Session
MORE
February 21, 2017
February 21, 2017
At the start of 2017, FDA approved two new abuse-deterrent opioids. Morphine sulfate (Arymo—Egalet) extended-release (ER) was given agency approval...
Experts are split on whether opioids with abuse-deterrent properties are the best answer to the prescription opioid abuse epidemic
MORE
January 03, 2017
January 03, 2017
FDA Center for Drug and Evaluation and Research Director Janet Woodcock, MD, joined the agency’s December 20, 2016, podcast to discuss the agency’s...
Opioid Action Plan initiatives include approval of warning label language and Medication Guides, potential addition of IR opioids to REMS program
MORE
December 21, 2016
December 21, 2016
On December 20, DEA released a notice that clarifies DEA’s renewal process. The December 20 notice is a welcome change for pharmacists because DEA’s...
DEA will maintain grace periods and other policies regarding registration renewals
MORE
December 19, 2016
December 19, 2016
CDC has released new tools and materials to give health care providers more resources to help curb prescription opioid abuse and overdose. Two of...
App and educational videos are among new resources
MORE
December 16, 2016
December 16, 2016
DEA has released a notice that could have serious implications for pharmacists, prescribers, researchers, manufacturers, distributors, and others...
DEA will end grace periods and adopt tougher policies to renew controlled substance registrations
MORE

Pages